# Rozanolixizumab (Genetical Recombination) S.C. Injection 280mg (リスティーゴ皮下注２８０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6399432A1028). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6399432A1028
- **Product name (Japanese):** リスティーゴ皮下注２８０ｍｇ
- **English title:** Rozanolixizumab (Genetical Recombination) S.C. Injection 280mg
- **Active ingredient:** ロザノリキシズマブ（遺伝子組換え）
- **Active ingredient (INN):** Rozanolixizumab (Genetical Recombination)
- **Strength / unit:** ２８０ｍｇ２ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 639 Other biological products (その他の生物学的製剤)
- **Manufacturer:** UCB Japan (ユーシービージャパン)
- **NHI price (reference only):** JPY 356392 per ２８０ｍｇ２ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6399432A1028
- **JSON:** https://www.nifujipharma.com/api/drugs/6399432A1028

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Rozanolixizumab%20(Genetical%20Recombination)%20S.C.%20Injection%20280mg%20(%E3%83%AA%E3%82%B9%E3%83%86%E3%82%A3%E3%83%BC%E3%82%B4%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%92%EF%BC%98%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206399432A1028#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Rozanolixizumab (Genetical Recombination)

- [Rozanolixizumab (Genetical Recombination) S.C. Injection 420mg (リスティーゴ皮下注４２０ｍｇ)](https://www.nifujipharma.com/drugs/6399432A2024) — ４２０ｍｇ３ｍＬ１瓶, UCB Japan